Cross-System Medicine and Global Health

139 pages. Medical hypotheses, clinical protocols, global health analysis.
All findings are correlations requiring validation.

Download PDF

776 KB · January 2026

Clinical Protocols & Guidelines

Evidence-based clinical resources derived from literature synthesis, available for healthcare providers.

Clinical Guide

22q11.2DS Clinical Management Guide for Primary Care

Practical guidance for primary care physicians managing 22q11.2DS patients. Covers screening recommendations, red flags, specialist referral criteria, and coordination of care.

Protocol

22q11.2DS Autoimmune Screening Protocol

Evidence-based screening protocol for early detection of autoimmune conditions in 22q11.2DS. Includes timing, tests, interpretation guidance, and follow-up pathways.

Pre-Registered Hypotheses

All hypotheses are publicly registered before validation attempts, ensuring scientific rigor and preventing post-hoc rationalization. These predictions await testing in appropriate cohorts.

Pre-Registered Hypothesis #1
"In patients with 22q11.2DS, elevated TLR9 signaling markers will predict development of autoimmune disease with an odds ratio > 3.0 within a 5-year follow-up period."
Population: 22q11.2DS cohort, ages 5-25
Outcome: New autoimmune diagnosis (SLE, ITP, thyroiditis, JIA)
Falsification: OR < 1.5 in adequately powered cohort
Status: Pre-registered, seeking validation cohort
Pre-Registered Hypothesis #2
"Combined inflammatory marker elevation (CRP, IL-6) and neurocognitive decline during adolescence predicts psychosis conversion with AUC > 0.75."
Population: 22q11.2DS adolescents, ages 12-22
Outcome: Conversion to psychosis spectrum disorder
Falsification: AUC < 0.60 in validation cohort
Status: Pre-registered, seeking validation cohort
Pre-Registered Hypothesis #3
"IBD prevalence in 22q11.2DS exceeds general population prevalence by at least 5-fold."
Population: 22q11.2DS registry cohorts
Outcome: IBD prevalence vs. matched controls
Falsification: Prevalence ratio < 2.0
Status: Pre-registered, epidemiological data needed

Our Approach to Publication

We believe in transparency. Rather than claiming finished work before it exists, we share our hypotheses openly. When manuscripts are completed and submitted, they will be posted here with full documentation.

Why Pre-Registration?

Pre-registering hypotheses before testing prevents "p-hacking" and post-hoc rationalization. It ensures that our predictions are genuine forecasts, not explanations retrofitted to data. If a hypothesis fails validation, we will report that failure transparently.